This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $286.91 in the latest trading session, marking a +0.07% move from the prior day.
HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Teladoc (TDOC) & Microsoft Partner to Reduce Administrative Woes
by Zacks Equity Research
Teladoc (TDOC) collaborates with Microsoft, enabling automatic clinical documentation with the help of AI.
3 Momentum Anomaly Stocks to Buy on Solid Earnings Rally
by Supriyo Bose
HCA Healthcare (HCA), Hubbell (HUBB) and Nu Holdings (NU) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Acadia Healthcare's (ACHC) New Facility Boosts Pennsylvania Reach
by Zacks Equity Research
Acadia Healthcare (ACHC) commences operations at one of the two hospitals, which form a part of its JV with Geisinger. The company is committed to offer enhanced behavioral health services in Pennsylvania.
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $296.56 in the latest trading session, marking a +0.2% move from the prior day.
Select Medical (SEM) Up 21% Year to Date: More Room to Run?
by Zacks Equity Research
Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating abilities.
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
by Zacks Equity Research
Here is how Aquestive Therapeutics (AQST) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Brokers Suggest Investing in HCA (HCA): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
5 Dividend Stocks With Strong Growth Prospects
by Sweta Killa
Dividend stocks like Toll Brothers (TOL), Darden Restaurants (DRI), Caterpillar (CAT), Microchip (MCHP) and HCA Healthcare (HCA) pose strong growth prospects.
4 Sector ETFs & Stocks to Bet on June Jobs Data
by Sanghamitra Saha
The U.S. economy added 209,000 jobs in June 2023, following a downwardly revised 306,000 in May, and below market forecasts of 225,000.
2 Soaring Stocks to Buy Now for Growth and Value
by Benjamin Rains
Let's dive into two stocks that have soared in 2023 and over the last decade that investors might want to buy for both near-term and long-term upside since they offer a wonderful combination of growth and value.
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?
by Zacks Equity Research
Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.
Molina (MOH) to Buy Bright Health's California Medicare Business
by Zacks Equity Research
Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal plan.
The Zacks Analyst Blog Highlights Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS
by Zacks Equity Research
Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS are included in this Analyst Blog.
Top Research Reports for Microsoft, Anheuser-Busch InBev & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Anheuser-Busch InBev SA/NV (BUD) and HCA Healthcare (HCA).
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
4 Hospital Stocks in Focus Amid Improving Industry Trends
by Kaibalya Pravo Dey
Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.